Abbott Laboratories Market Cap 2006-2018 | ABT

Abbott Laboratories market cap history and chart from 2006 to 2018. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. Abbott Laboratories market cap as of November 20, 2018 is $123.89B.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $123.892B $27.390B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $122.046B 18.71
Stryker (SYK) United States $62.759B 23.66
Boston Scientific (BSX) United States $48.834B 24.68
Baxter (BAX) United States $34.600B 22.34
Zimmer Biomet Holdings (ZBH) United States $23.151B 15.01
Smith & Nephew SNATS (SNN) United Kingdom $15.845B 0.00
ResMed (RMD) United States $14.616B 27.87
Perrigo (PRGO) Ireland $8.530B 12.95
Bio-Rad Laboratories (BIO) United States $8.041B 51.42
Canopy Growth (CGC) Canada $7.608B 0.00
Hill-Rom Holdings (HRC) United States $6.079B 19.27
Aurora Cannabis (ACB) Canada $5.873B 32.05
Haemonetics (HAE) United States $5.316B 46.75
ICU Medical (ICUI) United States $4.835B 26.94
Insulet (PODD) United States $4.492B 0.00
Hutchison China MediTech (HCM) China $4.108B 0.00
Agios Pharmaceuticals (AGIO) United States $3.867B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.782B 0.00
Neogen (NEOG) United States $3.211B 48.63
NuVasive (NUVA) United States $3.153B 29.33
National Vision Holdings (EYE) United States $2.871B 55.54
Quidel (QDEL) United States $2.378B 31.00
Aphria (APHA) $2.260B 0.00
NxStage Medical (NXTM) United States $1.935B 0.00
Phibro Animal Health (PAHC) United States $1.371B 19.41
AtriCure (ATRC) United States $1.182B 0.00
Cardiovascular Systems (CSII) United States $0.999B 1439.50
VAREX IMAGING (VREX) United States $0.974B 19.57
Meridian Bioscience (VIVO) United States $0.833B 26.55
OraSure Technologies (OSUR) United States $0.761B 42.86
Surmodics (SRDX) United States $0.759B 115.98
Eagle Pharmaceuticals (EGRX) United States $0.737B 23.64
MacroGenics (MGNX) United States $0.713B 0.00
PetIQ (PETQ) United States $0.704B 20.01
Cerus (CERS) United States $0.692B 0.00
Lantheus Holdings (LNTH) United States $0.627B 19.41
Omeros (OMER) United States $0.617B 0.00
Owens & Minor (OMI) United States $0.546B 6.18
LeMaitre Vascular (LMAT) United States $0.537B 26.39
NanoString Technologies (NSTG) United States $0.509B 0.00
Insys Therapeutics (INSY) United States $0.499B 0.00
TG Therapeutics (TGTX) United States $0.428B 0.00
Evolus (EOLS) United States $0.377B 0.00
Quanterix (QTRX) United States $0.376B 0.00
Utah Medical Products (UTMD) United States $0.342B 22.12
Cytosorbents (CTSO) United States $0.316B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.258B 0.00
Surface Oncology (SURF) United States $0.230B 0.00
Rockwell Medical (RMTI) United States $0.205B 0.00
Bovie Medical (BVX) United States $0.193B 0.00
BioLife Solutions (BLFS) United States $0.186B 250.75
Chimerix (CMRX) United States $0.168B 0.00
Fonar (FONR) United States $0.141B 7.07
Conatus Pharmaceuticals (CNAT) United States $0.136B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.116B 0.00
Chembio Diagnostics (CEMI) United States $0.108B 0.00
United-Guardian (UG) United States $0.080B 16.68
Female Health (VERU) United States $0.074B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.072B 0.00
InfuSystems Holdings (INFU) United States $0.068B 0.00
Trinity Biotech (TRIB) Ireland $0.059B 18.87
CAS Medical Systems (CASM) United States $0.051B 0.00
Neurotrope (NTRP) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Capricor Therapeutics (CAPR) United States $0.027B 0.00
Myomo (MYO) United States $0.023B 0.00
Akers Biosciences Inc (AKER) United States $0.022B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.017B 0.00
Senestech (SNES) United States $0.016B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00